Our focus is on the development of nuclease-free methods and design of booster systems to improve efficiency of nuclease-based genome editing technologies with unparalleled efficiency of gene targeting in eukaryotic cells via homologous recombination.
Our proprietary mini-chromosome amplification technology enables the transfer of entire biosynthetic pathways for high expression in plant chloroplasts: units are not integrated in the chloroplast genome, enabling high expression of large polycistrons.
Our unique transport systems enable shuttling nucleic acids into the mitochondria for further expression of genes of interest such as inducers of cytoplasmic male sterility for hybrid seed production.
Alexander is presenting Algentech’s technology and application to produce sustainable ingredients at this year’s EurekAwards finalhttps://www.linkedin.com/posts/eurekare_eurekawarads-2021-finalists-activity-6863881377884991489-ePfe
Read More
Algentech has been recently awarded a grant by the European Space Agency via its Open Space Innovation Platform (OSIP). The project entitled...
Read MoreAlgentech’s disruptive technology was published on June 21, 2021 in the journal Nature Plants https://doi.org/10.1038/s41477-021-00940-y). The process patented by Algentech makes it...
Read MoreLink to full interview here: Après 10 ans de développement, Algentech veut exporter sa technologie d’édition du génome végétal aux Etats-Unis (neftys.fr)...
Read More